Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1991
05/28/1991CA2030367A1 (1-alkylsubstituted) and (1,1-dialkylsubstituted) carbacephalosporins
05/28/1991CA1284498C Methylthioribose analogs, their preparation and use as medicinal agentsand biocides
05/25/1991CA2030776A1 Cyclopentane derivative
05/22/1991EP0428486A1 Polymyxin conjugates
05/22/1991EP0428440A1 Soluble, non-toxic derivatives of basic polyene macrolides, their preparation and use
05/22/1991EP0428132A1 Pradimicin derivatives
05/22/1991EP0428105A2 Use of quinolyl- and isoquinolyloxazole-2-ones for the production of a medicament for the prevention of glycoprotein enveloped virus infectivity
05/22/1991EP0428103A2 Prevention of glycoprotein enveloped virus infectivity by pyridyloxazole-2-ones
05/22/1991EP0427843A1 Specific inhibitor for retrovirus reverse transcriptase, and its application as a medicament.
05/22/1991EP0427781A1 Ozonides of terpenes and their medical uses
05/22/1991EP0427771A1 Macrolactam antimicrobial compounds
05/22/1991CN1051562A Novel compounds
05/22/1991CA2028530A1 Substituted pyrimidobenzimidazole derivatives
05/21/1991US5017701 Process for the preparation of purine derivatives
05/21/1991US5017569 Cephalosporin derivatives
05/21/1991CA2030254A1 Methods of treating retroviral infection
05/21/1991CA1284324C Carbapenem process
05/16/1991WO1991006653A1 Recombinant vaccine for porcine pleuropneumonia
05/16/1991WO1991006639A1 Recombinant production of lactoperoxidase
05/16/1991WO1991006629A1 Oligonucleotide analogs with novel linkages
05/16/1991WO1991006566A1 Novel compounds
05/16/1991WO1991006549A1 Cephalosporin compounds and production thereof
05/16/1991WO1991006548A1 Inhibitors of purine nucleoside phosphorylase
05/16/1991WO1991006311A1 Anti-viral material
05/16/1991WO1991006306A1 Antivenoms and methods for making antivenoms
05/16/1991DE4036130A1 New phosphonamide-contg. polypeptide derivs. - useful as bacterial collagenase inhibitors to treat gangrene and periodontal disease
05/16/1991DE4035456A1 Pharmaceutical composition
05/16/1991CA2071546A1 Anti-viral material
05/16/1991CA2029997A1 Polymyxin conjugates
05/15/1991EP0427587A1 Process for the preparation of AZT (3'-azido-3'-deoxy-thymidine) and related compounds
05/15/1991EP0427248A2 New cephem compounds and processes for preparation thereof
05/15/1991EP0427246A2 Pharmaceutical compositions comprising sulfur containing carboxylic acids as the active agent as well as their use for combatting retroviruses
05/15/1991EP0427190A2 Polyelectrolyte complexes for the treatment and the prophylaxis of viral diseases and process for their preparation
05/15/1991EP0426785A1 Compositions and methods for treating viral infections
05/15/1991EP0261234B1 Dual phase solvent carrier system
05/15/1991CN1051299A Methods and compasitions employing certain lysozymes and endoglycosidases
05/15/1991CN1012614B Ceph-3-ene-4-carboxylic acid derivatives and the prepn.
05/15/1991CA2029771A1 Soluble, non-toxic derivatives of basic polyenic macrolides, their preparation and their applications
05/14/1991US5015578 BMY-41950 antitumor antibiotic
05/14/1991CA2029766A1 Polypeptide compound and a process for preparation thereof
05/14/1991CA2029715A1 Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures
05/14/1991CA1284147C 7-(substituted) amino-3-substituted cephalosporanic acids and esters
05/14/1991CA1284109C Aqueous solution containing a quinolone carboxylic acid
05/14/1991CA1284108C Hair care compositions
05/11/1991CA2029638A1 Cephem compounds and processes for preparation thereof
05/08/1991EP0426314A2 HIV related peptides
05/08/1991EP0425507A1 Compositions and methods for treating skin conditions and promoting wound healing.
05/08/1991CN1051180A Therapeutic nucleosides
05/08/1991CN1051176A Quinolone compounds and process for their preparation
05/07/1991WO1991006554A1 Nucleoside derivatives
05/07/1991US5013841 Oxo quinoline derivatives
05/07/1991US5013833 Process for preparing cefuroxime axetil
05/07/1991US5013731 Bactericides
05/07/1991US5013730 Antibiotics
05/07/1991US5013729 Systemic Bactericides
05/07/1991US5013661 Lipopolysaccharide-specific acyloxyacyl hydrolase
05/07/1991US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents
05/07/1991US5013459 Opthalmic fluid dispensing method
05/07/1991CA2073063A1 Nucleoside derivatives
05/07/1991CA1283905C Cephalosporin derivatives, processes for their preparation and antibacterial agents
05/07/1991CA1283859C Penicillamine for treating immune damaging illnesses
05/04/1991WO1991006317A1 Cross-protective salmonella vaccines
05/04/1991WO1991006316A1 Reduced-protein subunit vaccine for swine dysentery
05/04/1991CA2072633A1 Cross-protective salmonella vaccines
05/02/1991WO1991006009A1 N-acetylmuramidase m1
05/02/1991WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases
05/02/1991WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals
05/02/1991WO1991005761A1 Treatment of hiv infections and compounds useful therein
05/02/1991WO1991005567A1 Vaccins for protecting against infections by hiv virus, process for producing the same and their use as diagnostic and immunotherapy means
05/02/1991WO1991005560A1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs
05/02/1991EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use
05/02/1991EP0425082A1 Bordetella vaccines
05/02/1991EP0425019A1 Methods and compositions employing certain lysozymes and endoglycosidases
05/02/1991EP0424851A1 Quinolone compounds and a process for their preparation
05/02/1991EP0424850A1 Quinolone compounds and a process for their preparation
05/02/1991EP0424832A2 Carbapenem compounds
05/02/1991EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship.
05/02/1991EP0424484A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection.
05/02/1991EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor
05/01/1991WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
05/01/1991WO1991006318A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna
05/01/1991WO1991006308A1 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
05/01/1991CN1051036A Treatment of hiv infections and compounds useful therein
05/01/1991CN1012501B Quinolonecarboxylic acid derivatives and their preparation
05/01/1991CN1012499B Compounds related to antibiotic tan-749 and their production
05/01/1991CA2044244A1 Antibacterial composition
05/01/1991CA2028758A1 Use of a benzodiazepine and a phenylpyrrylketone derivative
05/01/1991CA2028730A1 1-8 benzonaphtyridine derivatives, preparation and compositions thereof
04/1991
04/30/1991US5011850 Substituted diazolylalkyl-carbinols, a process for their preparation and their use as antimycotic agents
04/30/1991US5011829 Pharmaceutical composition and method of inhibiting virus
04/30/1991CA1283658C Process for quinoline-3-carboxylic acid antibacterial agents
04/30/1991CA1283656C Deoxyadenosine phosphate compounds and methods of making and using the same
04/28/1991WO1991006650A1 C1 inhibitor muteins and uses thereof
04/28/1991WO1991006561A1 Method for treating hiv and other retroviruses and compounds useful therefor
04/28/1991CA2071871A1 C1 inhibitor muteins and uses thereof
04/28/1991CA2066644A1 Method for treating hiv and other retroviruses and compounds useful therefor
04/28/1991CA2028648A1 Process for preparing azt (azido-3'-deoxy-3'-thymidine) and related compounds
04/27/1991WO1991006302A1 Ribozyme inhibitors
04/27/1991CA2071534A1 Ribozyme inhibitors
04/24/1991EP0424350A1 Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol
1 ... 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 ... 1798